CCR5 and infection: The CRISPR/Cas9 knockout CCR5 combined with C46 HIV-1 fusion inhibitor with/without AcGFP1 protected against cell death from both R5-tropic HIV-1BaL and X4-tropic HIV-1NL4-3 infections.